BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Drug Development

  Valeant Pharmaceuticals International Reports Encouraging Phase IIb Results at Treatment Week 12 for Taribavirin

  March 17, 2008

   · 

  5 min read
• Deals

  Bristol-Myers Squibb Company Weighs $7-9 Billion Baby Food Business Sale

  March 17, 2008

   · 

  1 min read
• Deals

  AVI BioPharma, Inc. Announces Acquisition of Ercole Biotech

  March 17, 2008

   · 

  6 min read
• Gene Variant Increases Breast Cancer Risk, German Cancer Research Center (DKFZ) Study

  March 17, 2008

   · 

  1 min read
• Drug Development

  Vasogen Provides Update on ACCLAIM II Program

  March 17, 2008

   · 

  5 min read
• Drug Development

  ALK-Abello A/S Present Successful Phase III Clinical Study Results with Children

  March 17, 2008

   · 

  5 min read
• Policy

  CV Therapeutics, Inc. Awaiting FDA Regadenoson Decision

  March 17, 2008

   · 

  1 min read
• Drug Development

  Cell Therapeutics, Inc. Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkin’s Lymphoma

  March 17, 2008

   · 

  5 min read
• Drug Development

  GlaxoSmithKline Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile

  March 17, 2008

   · 

  5 min read
• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Expands IBD Franchise with Addition of New Development Candidate

  March 17, 2008

   · 

  4 min read